Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Arthralgia During Anastrozole Therapy for Breast Cancer

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV

Treatment

Active

18 and over

Pharmaceutical / Industry

D5392L00013
2005-00-5441-19 EUDRACT number, NCT00323479

Trial Description

Summary

The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.

Eligibility Criteria

Inclusion Criteria:

Post menopausal woman with a breast cancer and scheduled for an adjuvant treatment with anastrozole

WHO performance status 0, 1 or 2

Provision of written informed consent

Exclusion Criteria:

Recurrence of breast cancer, inflammatory rheumatism

treatment by chondromodulator, oral glucocorticoid, aromatase inhibitor, anti estrogen, Herceptin

Diabetes treated by insulin

Severe renal or hepatic disease

Known hypersensitivity to anastrozole

Trial Contact Information

Trial Lead Organizations/Sponsors

AstraZeneca Pharmaceuticals LP

AstraZeneca France Medical Director, MD

Study Director

AstraZeneca France Medical Oncology Clinical Study Information

Ph: +33.1.41.29.40.00

Trial Sites

France

Bordeaux

Research Site

Caen

Research Site

Lyon

Research Site

Paris

Research Site

Poitiers

Research Site

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00323479
Information obtained from ClinicalTrials.gov on July 16, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.